Phase 4 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years old, both male and female, who have been diagnosed with schizophrenia confirmed through a psychiatric evaluation using standard diagnostic tools (DSM-5 and MINI assessment)
- People whose schizophrenia symptoms are rated as moderate or below on standard clinical rating scales (PANSS total score of 80 or under, and CGI-S score of 4 or under) at both the screening and baseline appointments
- People whose body weight falls within a healthy to moderately obese range (BMI between 18 and 40)
- People who are willing and able to stop taking all antipsychotic medications before the baseline visit, and who are able to follow the requirements of the study
Who may not be able to join:
- People who have been newly diagnosed with schizophrenia, or who have been diagnosed with any other DSM-5 mental health condition within the past 12 months
- People who have had an alcohol or drug use disorder within the past 12 months
- People with a significant medical condition or disorder that could affect their safety or the reliability of the study results
- People considered to be at risk of suicidal behaviour
- People who are pregnant or breastfeeding
- There may be additional criteria not listed here that the trial site will assess
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in voiding dynamics (Qmax) over time; Change from baseline in post-void residual volume (PVR) over time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.